Cite
A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity.
MLA
van de Kerkhof, P. C. M., et al. “A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis Vulgaris Regardless of Baseline Disease Severity.” Dermatology (10188665), vol. 210, no. 4, June 2005, pp. 294–99. EBSCOhost, https://doi.org/10.1159/000084753.
APA
van de Kerkhof, P. C. M., Wasel, N., Kragballe, K., Cambazard, F., & Murray, S. (2005). A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity. Dermatology (10188665), 210(4), 294–299. https://doi.org/10.1159/000084753
Chicago
van de Kerkhof, P. C. M., N. Wasel, K. Kragballe, F. Cambazard, and S. Murray. 2005. “A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis Vulgaris Regardless of Baseline Disease Severity.” Dermatology (10188665) 210 (4): 294–99. doi:10.1159/000084753.